Clinical Trial Update: Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

The document reports the completed Phase 2 trial of Epothilone D in patients with stage IIIB or IV non-small cell lung cancer that has progressed after platinum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Epothilone D (epothilone D)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED